• Fri, November 11, 2022

by: WOPRAI

Matthew Akers Maintained (TDG) at Buy with Decreased Target to $735 on, Nov 11th, 2022

by: WOPRAI

Scott Deuschle Maintained (TDG) at Buy with Increased Target to $718 on, Nov 11th, 2022

by: WOPRAI

Myles Walton Maintained (TDG) at Buy with Increased Target to $715 on, Nov 11th, 2022

by: WOPRAI

Keith Weiss Maintained (TEAM) at Buy with Decreased Target to $190 on, Nov 11th, 2022

by: WOPRAI

Tyler Radke Maintained (TDC) at Strong Buy with Increased Target to $42 on, Nov 11th, 2022

by: WOPRAI

Corey Tarlowe Maintained (TGT) at Strong Buy and Held Target at $185 on, Nov 11th, 2022

by: WOPRAI

Stephen Byrd Maintained (CNP) at Buy with Increased Target to $29 on, Nov 11th, 2022

by: WOPRAI

Stephen Byrd Maintained (CMS) at Hold with Increased Target to $60 on, Nov 11th, 2022

by: WOPRAI

David Arcaro Maintained (CEG) at Buy with Decreased Target to $97 on, Nov 11th, 2022

by: WOPRAI

Brian Gesuale Maintained (CDRE) at Buy with Increased Target to $32 on, Nov 11th, 2022

by: WOPRAI

Jeff Van Sinderen Maintained (CDRE) at Strong Buy with Increased Target to $38 on, Nov 11th, 2022

by: WOPRAI

Matt Koranda Maintained (CDRE) at Strong Buy with Increased Target to $32 on, Nov 11th, 2022

by: WOPRAI

Jason Kolbert Downgraded (BCDA) to Hold on, Nov 11th, 2022

by: WOPRAI

Jason Bednar Maintained (BDX) at Hold with Decreased Target to $245 on, Nov 11th, 2022

by: WOPRAI

Yatin Suneja Maintained (BIIB) at Hold with Increased Target to $270 on, Nov 11th, 2022

by: WOPRAI

Nik Modi Maintained (BGS) at Hold with Decreased Target to $16 on, Nov 11th, 2022

by: WOPRAI

Ronald Epstein Downgraded (SPR) to Sell and Decreased Target to $26 on, Nov 11th, 2022

by: WOPRAI

Stephen Byrd Maintained (SRE) at Hold with Increased Target to $77 on, Nov 11th, 2022

by: WOPRAI

Matthew Mishan Maintained (STE) at Buy with Decreased Target to $210 on, Nov 11th, 2022

by: WOPRAI

Stephen Byrd Maintained (SO) at Sell with Increased Target to $59 on, Nov 11th, 2022

by: WOPRAI

Nicholas Jones Maintained (SOND) at Buy with Decreased Target to $65 on, Nov 11th, 2022

by: WOPRAI

Erik Woodring Maintained (SMRT) at Hold with Increased Target to $2.9 on, Nov 11th, 2022

by: WOPRAI

Paul Quinn Maintained (SLVM) at Buy with Increased Target to $60 on, Nov 11th, 2022

by: WOPRAI

Thomas Wadewitz Upgraded (SNDR) to Strong Buy on, Nov 11th, 2022

by: WOPRAI

Robert Farnam Initiated (THG) at Strong Buy and Held Target at $164 on, Nov 11th, 2022

by: WOPRAI

Paul Lejuez Maintained (TJX) at Strong Buy with Increased Target to $86 on, Nov 11th, 2022

by: WOPRAI

Josh Beck Maintained (TOST) at Buy with Increased Target to $26 on, Nov 11th, 2022

by: WOPRAI

Mayank Tandon Maintained (TOST) at Strong Buy with Increased Target to $32 on, Nov 11th, 2022

by: WOPRAI

Jeff Cantwell Maintained (TOST) at Buy with Increased Target to $27 on, Nov 11th, 2022

by: WOPRAI

Josh Baer Maintained (TOST) at Buy with Increased Target to $30 on, Nov 11th, 2022

by: WOPRAI

Sandy Draper Maintained (TOI) at Strong Buy with Decreased Target to $6 on, Nov 11th, 2022

by: WOPRAI

Geulah Livshits Maintained (TNYA) at Strong Buy with Decreased Target to $28 on, Nov 11th, 2022

by: WOPRAI

Kimberly Greenberger Maintained (TPR) at Hold with Decreased Target to $35 on, Nov 11th, 2022

by: WOPRAI

Matthew Boss Maintained (TPR) at Buy with Decreased Target to $46 on, Nov 11th, 2022

by: WOPRAI

Kenneth Lee Maintained (TSLX) at Buy with Decreased Target to $21 on, Nov 11th, 2022

by: WOPRAI

Serge Belanger Maintained (TRVI) at Strong Buy with Decreased Target to $8 on, Nov 11th, 2022

by: WOPRAI

Ryan Todd Maintained (TTE) at Hold with Increased Target to $66 on, Nov 11th, 2022

by: WOPRAI

Vincent Colicchio Maintained (TTEC) at Buy with Decreased Target to $59 on, Nov 11th, 2022

by: WOPRAI

James Faucette Maintained (TTEC) at Sell with Decreased Target to $40 on, Nov 11th, 2022

by: WOPRAI

Craig Kucera Maintained (UMH) at Strong Buy with Decreased Target to $21 on, Nov 11th, 2022

by: WOPRAI

Matt Howlett Maintained (VCTR) at Strong Buy with Increased Target to $40 on, Nov 11th, 2022

by: WOPRAI

Nicholas Jones Maintained (VCSA) at Buy with Decreased Target to $100 on, Nov 11th, 2022

by: WOPRAI

Yatin Suneja Maintained (VIGL) at Strong Buy with Decreased Target to $19 on, Nov 11th, 2022

by: WOPRAI

John Glass Maintained (USFD) at Hold with Increased Target to $36 on, Nov 11th, 2022

by: WOPRAI

Stephen Byrd Maintained (ATO) at Buy with Increased Target to $120 on, Nov 11th, 2022

by: WOPRAI

Michael Sarcone Initiated (AXGN) at Strong Buy and Held Target at $15 on, Nov 11th, 2022

by: WOPRAI

Jonathan Wolleben Maintained (AURA) at Buy with Increased Target to $30 on, Nov 11th, 2022

by: WOPRAI

Scott Fidel Maintained (AVAH) at Hold with Decreased Target to $1.5 on, Nov 11th, 2022

Carter Gould Maintained (VOR) at Buy with Decreased Target to $15 on, Nov 11th, 2022

Carter Gould of Barclays, Maintained "Vor Biopharma Inc." (VOR) at Buy with Decreased Target from $26 to $15 on, Nov 11th, 2022.

Carter has made no other calls on VOR in the last 4 months.



There are 2 other peers that have a rating on VOR. Out of the 2 peers that are also analyzing VOR, 0 agree with Carter's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Carter

  • Swayampakula Ramakanth of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $20 on, Monday, August 15th, 2022
  • David Nierengarten of "Wedbush" Initiated at Buy and Held Target at $18 on, Tuesday, July 26th, 2022

Like: 👍